A pharmaceutical company based in Florida has announced that it will use XRP, the digital asset developed by Ripple, to facilitate real-time payments as part of a $50 million financing agreement.
In a recent statement, the company emphasized the benefits of integrating XRP and its associated technology into the healthcare sector. “We believe that there are significant advantages to incorporating XRP and its infrastructure into our healthcare ecosystem,” the company stated in the release.
The move highlights the growing interest in blockchain-based solutions for speeding up transactions and improving transparency in the pharmaceutical and healthcare industries